[go: up one dir, main page]

SI1610822T2 - Tekoče farmacevtske formulacije fsh in lh, skupaj z neionsko površinsko aktivno snovjo - Google Patents

Tekoče farmacevtske formulacije fsh in lh, skupaj z neionsko površinsko aktivno snovjo

Info

Publication number
SI1610822T2
SI1610822T2 SI200431587T SI200431587T SI1610822T2 SI 1610822 T2 SI1610822 T2 SI 1610822T2 SI 200431587 T SI200431587 T SI 200431587T SI 200431587 T SI200431587 T SI 200431587T SI 1610822 T2 SI1610822 T2 SI 1610822T2
Authority
SI
Slovenia
Prior art keywords
fsh
freeze
liquid
pharmaceutical formulations
ionic surfactant
Prior art date
Application number
SI200431587T
Other languages
English (en)
Other versions
SI1610822T1 (sl
Inventor
Fabrizio Samaritani
Piergiorgio Donati
Original Assignee
Ares Trading S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33135521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1610822(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.
Publication of SI1610822T1 publication Critical patent/SI1610822T1/sl
Publication of SI1610822T2 publication Critical patent/SI1610822T2/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
SI200431587T 2003-04-02 2004-04-02 Tekoče farmacevtske formulacije fsh in lh, skupaj z neionsko površinsko aktivno snovjo SI1610822T2 (sl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP03100882 2003-04-02
EP03101543 2003-05-27
EP03101828 2003-06-20
EP04725385.1A EP1610822B2 (en) 2003-04-02 2004-04-02 Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant
PCT/EP2004/050432 WO2004087213A1 (en) 2003-04-02 2004-04-02 Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant

Publications (2)

Publication Number Publication Date
SI1610822T1 SI1610822T1 (sl) 2011-02-28
SI1610822T2 true SI1610822T2 (sl) 2018-12-31

Family

ID=33135521

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431587T SI1610822T2 (sl) 2003-04-02 2004-04-02 Tekoče farmacevtske formulacije fsh in lh, skupaj z neionsko površinsko aktivno snovjo

Country Status (24)

Country Link
US (1) US7741268B2 (sl)
EP (1) EP1610822B2 (sl)
JP (1) JP4699991B2 (sl)
KR (1) KR101105486B1 (sl)
AR (1) AR043972A1 (sl)
AT (1) ATE492292T2 (sl)
AU (1) AU2004226666B9 (sl)
BR (1) BRPI0409532B8 (sl)
CA (1) CA2518903C (sl)
CY (1) CY1111291T1 (sl)
DE (1) DE602004030673D1 (sl)
DK (1) DK1610822T4 (sl)
EA (1) EA012565B1 (sl)
HR (1) HRP20100727T4 (sl)
IL (1) IL171151A (sl)
ME (1) ME00217B (sl)
MX (1) MXPA05010635A (sl)
NO (1) NO330214B1 (sl)
NZ (1) NZ542247A (sl)
PL (1) PL1610822T5 (sl)
PT (1) PT1610822E (sl)
RS (2) RS57872B1 (sl)
SI (1) SI1610822T2 (sl)
WO (1) WO2004087213A1 (sl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY139088A (en) * 2005-02-21 2009-08-28 Lg Life Sciences Ltd Sustained release composition of protein drug
TWI369401B (en) * 2005-07-05 2012-08-01 Ares Trading Sa Serum-free culture medium for the production of recombinant gonadotropins
AU2006290662B2 (en) 2005-09-14 2010-12-23 Ares Trading S.A. Method for the quantitative determination of poloxamers
KR101105871B1 (ko) * 2005-09-27 2012-01-16 주식회사 엘지생명과학 인 난포자극호르몬의 안정한 용액 제형
US8664369B2 (en) * 2007-11-01 2014-03-04 Merck Serono S.A. LH liquid formulations
ME01337B (me) 2008-02-08 2013-12-20 Biogenerix Ag Tečni preparat fsh
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
CN102309747B (zh) * 2008-09-17 2013-04-17 上海天伟生物制药有限公司 高纯度绝经期促性腺素冻干针剂
MX2011004453A (es) 2008-11-04 2011-08-12 Aska Pharm Co Ltd Composicion acuosa que contiene hormona foliculo estimulante.
AU2010234028B2 (en) 2009-04-01 2013-11-14 Theramex HQ UK Limited Method for purifying recombinant FSH
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
WO2011076117A1 (zh) * 2009-12-22 2011-06-30 上海天伟生物制药有限公司 绝经期促性腺素组合物
WO2012127500A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for spermatogenesis
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
KR101699677B1 (ko) * 2013-11-12 2017-01-24 카딜라 핼쓰캐어 리미티드 고나도트로핀을 위한 제제
ES2719748T3 (es) * 2014-05-23 2019-07-12 Inst Massone S A Proceso para obtener HMG-UP (gonadotropina menopáusica humana con grado de ultrapureza) y una composición libre de contaminantes
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
TWI865430B (zh) * 2017-07-24 2024-12-11 美商再生元醫藥公司 穩定化之抗體組合物及其製法

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB839300A (en) 1957-09-05 1960-06-29 Organon Labor Ltd Adrenocorticotropic hormone preparations and process for making same
FR3819M (fr) 1963-03-11 1966-01-10 Serono Ist Farm Nouvelle hormone hypophysaire a activité différenciée.
EP0082481B2 (en) * 1981-12-23 1990-09-12 Schering Corporation Stabilised alpha-interferon formulations and their preparation
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US5639639A (en) * 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US4589402A (en) * 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US5162306A (en) * 1987-01-23 1992-11-10 Donaldson Lloyd E Composition and method for producing superovulation in mammals
US4780451B1 (en) 1987-01-23 1995-04-04 Asua International Inc Composition and method for producing superovulation in cattle
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
ZA888577B (en) * 1987-11-27 1989-08-30 Akzo Nv Stabilization of antibodies
US5096885A (en) 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5384132A (en) * 1990-03-20 1995-01-24 Akzo N.V. Stabilized gonadotropin containing preparations
US5374620A (en) * 1990-06-07 1994-12-20 Genentech, Inc. Growth-promoting composition and its use
DE4117078A1 (de) 1991-05-25 1992-11-26 Boehringer Ingelheim Kg Verfahren zur herstellung therapeutisch anwendbarer aerosole
US5508261A (en) * 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
EP0673383B1 (en) 1991-06-18 2000-05-31 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
IT1250075B (it) 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US5356876A (en) * 1992-01-13 1994-10-18 Trinity University Methods of terminating pregnancy
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
DE69334134T2 (de) 1992-07-31 2007-12-20 Genentech, Inc., South San Francisco Wässrige Formulierung enthaltend Menschliches Wachstumshormon
US5661125A (en) * 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
ES2164098T3 (es) * 1993-02-02 2002-02-16 Xoma Technology Ltd Composiciones farmaceuticas que contienen una proteina bactericida aumentadora de la permeabilidad y un tensioactivo.
US6238890B1 (en) * 1994-02-18 2001-05-29 Washington University Single chain forms of the glycoprotein hormone quartet
US5594091A (en) 1994-02-21 1997-01-14 Takeda Chemical Industries, Ltd. Matrix for sustained-release preparation
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
DE69528080T2 (de) * 1994-12-22 2003-06-05 Ortho Pharma Corp Lösliche arzneizusammensetzungen enthaltend 2-chloro-2'-deoxyadenosine
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
AU5004196A (en) * 1995-03-10 1996-10-02 Boehringer Mannheim Gmbh Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof
TW426523B (en) 1995-04-06 2001-03-21 Hoffmann La Roche Interferon solution
FR2733914B1 (fr) 1995-05-11 1997-08-01 Sanofi Sa Composition de liquide stable contenant de l'urate oxydase et composition lyophilisee pour sa preparation
DK1516628T3 (da) 1995-07-27 2013-09-08 Genentech Inc Stabil, isotonisk lyofiliseret proteinformulering
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
ATE255903T1 (de) 1995-11-07 2003-12-15 Genentech Inc Stabilisierende formulierung für ngf
KR20000069680A (ko) * 1996-12-23 2000-11-25 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 액체 약제 저장을 위한 선형 올레핀 중합체로 된 약제 용기
US6136784A (en) * 1997-01-08 2000-10-24 Amylin Pharmaceuticals, Inc. Amylin agonist pharmaceutical compositions containing insulin
AU740918B2 (en) 1997-01-10 2001-11-15 Plantibodies Corporation Novel epithelial tissue targeting agent
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
US20010007673A1 (en) * 1999-11-12 2001-07-12 Merrill Seymour Goldenberg Sustained-release delayed gels
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6287587B2 (en) 1997-07-15 2001-09-11 Takeda Chemical Industries, Ltd. Process for producing sustained-release preparation by in-water drying
WO1999021534A1 (en) 1997-10-27 1999-05-06 Merck Patent Gmbh Solid state solutions and dispersions of poorly water soluble drugs
ZA9811127B (en) 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
BR9912243A (pt) * 1998-07-23 2001-10-16 Lilly Co Eli Formulações de fsh e variantes de fsh, produtos e processos
US20020165146A1 (en) * 1998-07-23 2002-11-07 Hoffman James Arthur FSH article of manufacture
FR2782455B3 (fr) 1998-08-20 2000-09-15 Sanofi Sa Composition pharmaceutique injectable a base d'un sel pharmaceutiquement acceptable du clopidogrel ou de ticlopidine
AU765584B2 (en) * 1998-09-17 2003-09-25 Eli Lilly And Company Protein formulations
CA2377791A1 (en) 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Novel polypeptide and dna thereof
US6573237B2 (en) * 2001-03-16 2003-06-03 Eli Lilly And Company Protein formulations
NZ535008A (en) 2002-02-08 2005-09-30 Alkermes Inc Polymer-based compositions for sustained release

Also Published As

Publication number Publication date
RS20050737A (sr) 2007-11-15
AR043972A1 (es) 2005-08-17
WO2004087213A1 (en) 2004-10-14
SI1610822T1 (sl) 2011-02-28
DE602004030673D1 (de) 2011-02-03
PT1610822E (pt) 2011-01-05
WO2004087213A8 (en) 2005-03-17
KR20050110037A (ko) 2005-11-22
BRPI0409532A (pt) 2006-04-18
HRP20100727T4 (hr) 2018-11-16
CA2518903C (en) 2013-02-05
HK1086503A1 (en) 2006-09-22
JP2006522072A (ja) 2006-09-28
EP1610822B2 (en) 2018-09-19
NO20054982L (no) 2005-10-26
ATE492292T2 (de) 2011-01-15
MEP31708A (en) 2010-10-10
US20060147480A1 (en) 2006-07-06
CY1111291T1 (el) 2015-08-05
ME00217B (me) 2011-02-10
PL1610822T5 (pl) 2019-05-31
IL171151A (en) 2014-11-30
EP1610822A1 (en) 2006-01-04
HRP20100727T1 (hr) 2011-02-28
KR101105486B1 (ko) 2012-01-13
AU2004226666B9 (en) 2010-04-08
NZ542247A (en) 2008-03-28
NO330214B1 (no) 2011-03-07
US7741268B2 (en) 2010-06-22
AU2004226666B2 (en) 2009-09-03
EP1610822B1 (en) 2010-12-22
PL1610822T3 (pl) 2011-06-30
DK1610822T4 (en) 2019-01-14
RS57872B1 (sr) 2018-12-31
AU2004226666A1 (en) 2004-10-14
BRPI0409532B8 (pt) 2021-05-25
JP4699991B2 (ja) 2011-06-15
CA2518903A1 (en) 2004-10-14
EA200501531A1 (ru) 2006-06-30
MXPA05010635A (es) 2005-12-12
BRPI0409532B1 (pt) 2019-09-17
DK1610822T3 (da) 2011-01-31
EA012565B1 (ru) 2009-10-30

Similar Documents

Publication Publication Date Title
PL1610822T5 (pl) Płynne formulacje farmaceutyczne FSH i LH z niejonowym surfaktantem
PT1757606E (pt) Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação
SI1478339T1 (sl) Farmacevtske formulacije antineoplastičnih sredstev, zlasti temozolomida, postopki za pripravo in uporabo le-teh
IL159025A0 (en) Hydrophobic dopamine agonists administered to the dermis
PL365245A1 (en) Aqueous pesticide formulations and novel surfactants
IL172841A0 (en) Active agents combination exhibiting insecticidal and acaricide properties
GB2375913B (en) Camera with visible and infra-red imaging
AU2002328343A1 (en) Wax-based compositions and the use thereof as body care agents
IL161587A0 (en) Pharmaceutical containing 3 (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol and providing delayed release of the active ingredient
EP1372739A4 (en) STABILIZED THERAPEUTIC AND IMAGING AGENTS
IL150383A0 (en) Glyburide and pharmaceutical compositions containing the same
GB0100548D0 (en) Formulation for the prevention of cardiovascular disease
HRP20040171A2 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
GB0101035D0 (en) Formulation and use thereof
HUP0500127A3 (en) Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient
IT1321215B1 (it) Dispositivo per la movimentazione e l'orientamento degli ugellispruzzatori in una bassina .
IL172806A0 (en) Active agents combination exhibiting insecticidal and acaricide properties
AU2001254961A1 (en) Agrochemical spray treatment and spray formulations
ZA200306545B (en) Medicinal compositions comprising diclofenac and ornoprostil.
EP1439315A4 (en) COMPOSITION FOR USE AS SELF-BLOCKING AGENT AND THIS USING SELF-BLOCKING LINK
AU2003291757A8 (en) Formulations of low solubility bioactive agents and processes for making the same
GB2364640B (en) Anti-ulcer pharmaceutical composition and the preparation thereof
ZA200300055B (en) Anthelminthic agents for the prevention of parasitic infections in humans and animals II.
AU2001272552A1 (en) Oxygen-enriched agent and the use thereof for therapeutic purposes
HUP0301579A3 (en) Anthelminthic composition for the prevention of parasitic infections in humans and animals and use thereof